Lifecare’s fair value price target holds steady at NOK 0.65 per share, with the key changes instead sitting in the assumptions behind the discount rate and growth outlook. Analysts covering tech ...
The west Nashville retiree and his wife had been billed through their Medicare supplemental insurance for genetic testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results